87 related articles for article (PubMed ID: 26130140)
41. Current and future molecular diagnostics in non-small-cell lung cancer.
Li CM; Chu WY; Wong DL; Tsang HF; Tsui NB; Chan CM; Xue VW; Siu PM; Yung BY; Chan LW; Wong SC
Expert Rev Mol Diagn; 2015; 15(8):1061-74. PubMed ID: 26153330
[TBL] [Abstract][Full Text] [Related]
42. Predictive biomarkers in precision medicine and drug development against lung cancer.
Fang B; Mehran RJ; Heymach JV; Swisher SG
Chin J Cancer; 2015 Jul; 34(7):295-309. PubMed ID: 26134262
[TBL] [Abstract][Full Text] [Related]
43. CaCO₃/CaIP₆ composite nanoparticles effectively deliver AKT1 small interfering RNA to inhibit human breast cancer growth.
Zhou H; Wei J; Dai Q; Wang L; Luo J; Cheang T; Wang S
Int J Nanomedicine; 2015; 10():4255-66. PubMed ID: 26170662
[TBL] [Abstract][Full Text] [Related]
44. EGFR and KRAS mutations in pulmonary pleomorphic carcinoma and their correlation with clinicopathologic features.
Jia X; Chen G
Contemp Oncol (Pozn); 2015; 19(1):22-7. PubMed ID: 26199566
[TBL] [Abstract][Full Text] [Related]
45. Systemic delivery of micelles loading with paclitaxel using N-succinyl-palmitoyl-chitosan decorated with cRGDyK peptide to inhibit non-small-cell lung cancer.
Yuan ZQ; Li JZ; Liu Y; Chen WL; Yang SD; Zhang CG; Zhu WJ; Zhou XF; Liu C; Zhang XN
Int J Pharm; 2015 Aug; 492(1-2):141-51. PubMed ID: 26188316
[TBL] [Abstract][Full Text] [Related]
46. Circulating miRNAs is a potential marker for gefitinib sensitivity and correlation with EGFR mutational status in human lung cancers.
Zhao Q; Cao J; Wu YC; Liu X; Han J; Huang XC; Jiang LH; Hou XX; Mao WM; Ling ZQ
Am J Cancer Res; 2015; 5(5):1692-705. PubMed ID: 26175938
[TBL] [Abstract][Full Text] [Related]
47. A study of the relationship of metabolic MR parameters to estrogen dependence in breast cancer xenografts.
Liu T; Nath K; Liu W; Zhou R; Chen IW
NMR Biomed; 2015 Sep; 28(9):1087-96. PubMed ID: 26174437
[TBL] [Abstract][Full Text] [Related]
48. Clinicopathologic characteristics and prognostic factors for HER2-positive patients with metastatic breast cancer in southern China.
Qin T; Yuan ZY; Peng RJ; Bai B; Zeng YD; Shi YX; Teng XY; Liu DG; Wang SS
Arch Med Sci; 2015 Jun; 11(3):544-50. PubMed ID: 26170847
[TBL] [Abstract][Full Text] [Related]
49. High levels of phosphatase and tensin homolog expression predict favorable prognosis in patients with non-small cell lung cancer.
Li XB; Yang Y; Zhang HQ; Yue WT; Zhang TM; Lu BH; Li J; Liu Z; Wang QH; Gao Y; Hu AM; Zhang HM; Shi HL; Hu FB; Li BL
Eur Rev Med Pharmacol Sci; 2015 Jun; 19(12):2231-9. PubMed ID: 26166648
[TBL] [Abstract][Full Text] [Related]
50. Deep sequencing analysis of microRNA expression in human melanocyte and melanoma cell lines.
Ding N; Wang S; Yang Q; Li Y; Cheng H; Wang J; Wang D; Deng Y; Yang Y; Hu S; Zhao H; Fang X
Gene; 2015 Nov; 572(1):135-145. PubMed ID: 26164755
[TBL] [Abstract][Full Text] [Related]
51. The gene pair PRR11 and SKA2 shares a NF-Y-regulated bidirectional promoter and contributes to lung cancer development.
Wang Y; Zhang Y; Zhang C; Weng H; Li Y; Cai W; Xie M; Long Y; Ai Q; Liu Z; Du G; Wang S; Niu Y; Song F; Ozaki T; Bu Y
Biochim Biophys Acta; 2015 Sep; 1849(9):1133-44. PubMed ID: 26162986
[TBL] [Abstract][Full Text] [Related]
52. Helicobacter pylori virulence factor CagA promotes tumorigenesis of gastric cancer via multiple signaling pathways.
Yong X; Tang B; Li BS; Xie R; Hu CJ; Luo G; Qin Y; Dong H; Yang SM
Cell Commun Signal; 2015 Jul; 13():30. PubMed ID: 26160167
[TBL] [Abstract][Full Text] [Related]
53. Association between BIM deletion polymorphism and clinical outcome of EGFR-mutated NSCLC patient with EGFR-TKI therapy: A meta-analysis.
Ma JY; Yan HJ; Gu W
J Cancer Res Ther; 2015; 11(2):397-402. PubMed ID: 26148607
[TBL] [Abstract][Full Text] [Related]
54. Chemotherapy plus Erlotinib versus Chemotherapy Alone for Treating Advanced Non-Small Cell Lung Cancer: A Meta-Analysis.
Xu JL; Jin B; Ren ZH; Lou YQ; Zhou ZR; Yang QZ; Han BH
PLoS One; 2015; 10(7):e0131278. PubMed ID: 26147288
[TBL] [Abstract][Full Text] [Related]
55. Icotinib might be effective for the treatment of leptomeningeal carcinomatosis in non-small cell lung cancer with sensitive EGFR mutations.
Gong L; Xiong M; Huang Z; Miao L; Fan Y
Lung Cancer; 2015 Sep; 89(3):268-73. PubMed ID: 26141219
[TBL] [Abstract][Full Text] [Related]
56. Epidermal growth factor receptor mutation heterogeneity analysis of pulmonary sarcomatoid carcinoma successfully treated with erlotinib: A case report.
Zou F; Xie G; Ma JA; Zhou DA; Jiang YI; Zheng JY
Oncol Lett; 2015 May; 9(5):2239-2243. PubMed ID: 26137049
[TBL] [Abstract][Full Text] [Related]
57. Association between EML4-ALK fusion gene and thymidylate synthase mRNA expression in non-small cell lung cancer tissues.
Xu CW; Wang G; Wang WL; Gao WB; Han CJ; Gao JS; Zhang LY; Li Y; Wang L; Zhang YP; Tian YW; Qi DD
Exp Ther Med; 2015 Jun; 9(6):2151-2154. PubMed ID: 26136951
[TBL] [Abstract][Full Text] [Related]
58. Identification of a Novel ALK G1123S Mutation in a Patient with ALK-rearranged Non-small-cell Lung Cancer Exhibiting Resistance to Ceritinib.
Toyokawa G; Inamasu E; Shimamatsu S; Yoshida T; Nosaki K; Hirai F; Yamaguchi M; Seto T; Takenoyama M; Ichinose Y
J Thorac Oncol; 2015 Jul; 10(7):e55-7. PubMed ID: 26134233
[No Abstract] [Full Text] [Related]
59. Five water-soluble zwitterionic copper(II)-carboxylate polymers: role of dipyridyl coligands in enhancing the DNA-binding, cleaving and anticancer activities.
Chen M; Tang XY; Yang SP; Li HH; Zhao HQ; Jiang ZH; Chen JX; Chen WH
Dalton Trans; 2015 Aug; 44(29):13369-77. PubMed ID: 26131732
[TBL] [Abstract][Full Text] [Related]
60. A systematic analysis of human lipocalin family and its expression in esophageal carcinoma.
Du ZP; Wu BL; Wu X; Lin XH; Qiu XY; Zhan XF; Wang SH; Shen JH; Zheng CP; Wu ZY; Xu LY; Wang D; Li EM
Sci Rep; 2015 Jul; 5():12010. PubMed ID: 26131602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
